Sign in

CIK 0001082554

  • Large accelerated filer

UNITED THERAPEUTICS Corp

Sign in to watch
Ticker
UTHR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
521984749
Phone
+1 301-608-9292
Business address
1000 SPRING ST, SILVER SPRING, MD, 20910
  1. 4 Open-market sale Director sold 4,560 shares at $403.36 ($1,839,322)
  2. 4 Planned sale EVP & GENERAL COUNSEL sold 11,000 shares at an average $385.21 ($4,237,281)
  3. 4 Planned sale PRESIDENT AND COO sold 22,500 shares at an average $417.64 ($9,396,837)
  4. 4 Planned sale Director sold 3,000 shares at an average $423.21 ($1,269,630)
  5. 4 Planned sale EVP & GENERAL COUNSEL sold 11,000 shares at an average $308.75 ($3,396,249)
  6. 4 Planned sale EVP & GENERAL COUNSEL sold 11,000 shares at an average $300.00 ($3,299,981)
  7. 4 Derivatives Options or other derivatives
  8. 4 Exercise or conversion Director acquired 590 shares (option exercise)
  9. 4 Exercise or conversion Director acquired 1,190 shares (option exercise)
  10. 4 Exercise or conversion Director acquired 590 shares (option exercise)
  11. 4 Derivatives Options or other derivatives
  12. 4 Exercise or conversion Director acquired 590 shares (option exercise)
  13. 4 Exercise or conversion Director acquired 1,190 shares (option exercise)
  14. 4 Exercise or conversion Director acquired 590 shares (option exercise)
  15. 4 Derivatives Options or other derivatives
  16. 4 Exercise or conversion Director acquired 1,190 shares (option exercise)
  17. 4 Exercise or conversion Director acquired 1,220 shares (option exercise)
  18. 4 Planned sale EVP & GENERAL COUNSEL sold 11,000 shares at an average $304.11 ($3,345,225)
  19. 4 Planned sale EVP & GENERAL COUNSEL sold 11,000 shares at an average $300.31 ($3,303,394)
  20. 4 Planned sale EVP & GENERAL COUNSEL sold 11,000 shares at an average $285.70 ($3,142,718)

Page 20 of 164 · 3,272 filings